Skip to main content

Fettstoffwechselstörungen

  • Chapter
Phytopharmaka-Report

Zusammenfassung

Dyslipoproteinämien sind Stoffwechselstörungen insbesondere mit Konzentrationsveränderungen eines oder mehrerer Lipoproteine im Plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

allgemein zu Fettstoffwechselstörungen

  • Absmann G, Cullen P (1995) Erkennung und Behandlung von Fettstoffwechselstörungen. Nationale Cardiovaskuläre Initiative. Beilage zum Dtsch Arzteblatt Heft 51 /52

    Google Scholar 

  • Krone W, Müller-Wieland D (1994) Internist 35: 640–664

    PubMed  CAS  Google Scholar 

  • März W et al (1995) Dtsch Apotheker Ztg 11: 17–34

    Google Scholar 

  • Schwandt P (1996) Diagnostik und Therapie von Fettstoffwechselstörungen in der hausärztlichen Praxis. Empfehlungen der Deutschen Gesellschaft zur Bekämpfung von Fettstoffwechselstörungen und ihren Folgeerkrankungen DGFF (Lipa-Liga) e. V. Sonderbeilage zum Dtsch Arzteblatt Heft 4

    Google Scholar 

  • Wanner C, Wieland H (1995) In: Elger E, Heinertz T, Kalden R. (Hrsg) Therapiehandbuch. Urban und Schwarzenberg, München

    Google Scholar 

  • Beck E, Grünwald J (1993) Allium sativum in der Stufentherapie der Hyperlipidämie. Med Welt 44: 516–520

    Google Scholar 

  • Chang MLW, Johnson MA (1980) Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr 110: 931–936

    PubMed  CAS  Google Scholar 

  • Gebhardt R (1993) Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 28 (6): 613–619

    Article  PubMed  CAS  Google Scholar 

  • Gebhardt R, Beck H, Wagner KG (1994) Inhibition of cholesterol biosynthesis by allicin and ajoene in rat hepatocytes and HepG2 cells. Biochem Biophys Acta 1213: 57–62

    Article  PubMed  CAS  Google Scholar 

  • Heinle H, Betz E (1994) Effects of dietary garlic supplementation in a rat model of atherosclerosis. Arzneimittelforsch/Drug Res 44 (1): 614–617

    CAS  Google Scholar 

  • Holzgartner H, Schmidt U, Kuhn U (1992) Wirksamkeit and Verträglichkeit eines Knoblauchpulver-Präparates im Vergleich mit Bezafibrat. Arzneimittelforsch/Drug Res 42: 1473–1477

    CAS  Google Scholar 

  • Jain RC (1975) Onion and garlic in experimental cholesterol atherosclerosis in rabbits I. Effect on serum lipids and development of atherosclerosis. Atery 1: 115–125

    Google Scholar 

  • Jain RC (1977) Effect of garlic on serum lipids, coagulability and fibrinolytic activity of blood. Am J Clin Nutr 30: 1380–1381

    PubMed  CAS  Google Scholar 

  • Kiesewetter H, Jung EM, Mrowietz C, Koscielny J, Wenzel E (1993) Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. Eur J Clin Pharmacol 45: 333–336

    Article  PubMed  CAS  Google Scholar 

  • Kiesewetter H, Jung F, Jung EM, Blume J, Mrowietz C, Birk A, Koscielny J, Wenzel E (1993) Effects of garlic coated tablets in peripheral arterial occlusive disease. Clin Invest 71: 383–386

    Article  CAS  Google Scholar 

  • Mader FH, Auer W, Becker W, Böhm W, Brüchert E, Deutsch S (1990) Hyperlipidämie-Behandlung mit Knoblauch-Dragees. Der Allgemeinarzt 12: 435–440

    Google Scholar 

  • Quereshi AA, Abiurmeileh N, Din ZZ, Elson CE, Burger WC (1983) Inhibition of cholesterol and fatty acid biosynthesis in liver enzymes and chicken hepatocytes by polar fractions of garlic. Lipids 18: 343–348

    Article  Google Scholar 

  • Reuter HD (1995) Allium sativum and allium ursinum: Part 2. Pharmacology and medical application. Phytomedicine 2: 73–91

    Article  Google Scholar 

  • Reuter HD (1996) Therapeutic effects and applications of garlic and its preparations. In: Koch HP, Lawson DL (eds) Garlic — the science and therapeutic application of allium sativum 1 and related species, 2nd edn. Williams und Wilkins, Baltimore, pp 135–212

    Google Scholar 

  • Reuter HD, Sendl A (1994) Allium sativum and allium ursinum: chemistry, pharmacology and medical application. Econo Med Plant Res 6: 56–108

    Google Scholar 

  • Silagy C, Neil A (1994) Garlic as a lipid lowering agent — a meta-analysis. J R Coll Physicians 28 (1): 2–8

    Google Scholar 

  • Sumiyoshi H, Kanezawa A, Masamoto K, Harada H, Nakagami S, Yokota A (1984) Chronic toxicity text of garlic extracts in rats. J Toxicol Sci 9:61–75

    Google Scholar 

  • Warshafsky S, Kramer RS, Sivak L (1993) Effect of garlic on total serum cholesterol. Ann Inter Med 119: 599–605

    CAS  Google Scholar 

  • Zacharias NT, Sebastian KL, Philip B, Augusti KT (1980) Hypoglycemic and hypolipidaemic effects of garlic in sucrose fed rabbits. Ind J Physiol Pharmac 24: 151–154

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Loew, D., Habs, M., Klimm, HD., Trunzler, G. (1998). Fettstoffwechselstörungen. In: Phytopharmaka-Report. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-53753-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-53753-0_14

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1107-1

  • Online ISBN: 978-3-642-53753-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics